Peter Eckl

4.6k citations
98 papers · 3.6k indexed · h-index 30

Peter Eckl

91 papers receiving 3.5k citations

Peers

Peter Eckl
Comparison fields: 5 of 157
  • Biochemistry 459
  • Toxicology 158
  • Complementary and alternative medicine 368
  • Cancer Research 605
  • Rehabilitation 194
Replace Fung‐Jou Lu with:
Fung‐Jou Lu Taiwan
Saibal K. Biswas United States
Zhen Jiang China
Truyen Nguyen United States
Peramaiyan Rajendran India
Orazio Cantoni Italy
Aruna Kode United States
Miao‐Lin Hu Taiwan
L. W. Oberley United States
Cecil B. Pickett United States
Peter Eckl relative to Fung‐Jou Lu Taiwan Fung‐Jou Lu's profile →
Citations per field
00.5×2.7×
Fung‐Jou Lu · 1×
Citations per year

Countries citing papers authored by Peter Eckl

Since Specialization
Citations

This map shows the geographic impact of Peter Eckl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Eckl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Eckl more than expected).

Fields of papers citing papers by Peter Eckl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Eckl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Eckl. The network helps show where Peter Eckl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Eckl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Eckl Line = papers co-authored together Peter Eckl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 202013
3 20198
4 20187
5 201710
6 20146
7 201111
8 20119
9 200728
10 200599
11 200518
12 200435
13 200360
14 200213
15 19946
16 199340
17 199313
18 199313
19 199114
20 198849

About Peter Eckl

Peter Eckl is a scholar working on Cancer Research, Biochemistry and Hepatology, having authored 98 papers that have together received 3.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (32 papers), Antioxidant Activity and Oxidative Stress (12 papers), Free Radicals and Antioxidants (9 papers), Liver physiology and pathology (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Nigella sativa pharmacological applications (5 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Biochemistry (459 citations), Toxicology (158 citations) and Complementary and alternative medicine (368 citations). Peter Eckl has collaborated with scholars based in Austria, Germany and Kosovo. Frequent co-authors include Nikolaus Bresgen, M. Khader, Peter Steinbacher, Andreas Ortner, Werner Siems, Hermann Esterbauer, Randy L. Jirtle, Kôji Uchida, Françoise Guéraud and Laurence Huc. Their work appears in journals such as Journal of Cellular Physiology, Free Radical Biology and Medicine, The Science of The Total Environment, Mutation research. Fundamental and molecular mechanisms of mutagenesis and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026